https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48191 Sat 11 Mar 2023 12:30:28 AEDT ]]> Diagnostic yield of initial and consecutive blood cultures in children with cancer and febrile neutropenia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46401 P < .001). Two-thirds of the post-antibiotic BSIs were associated with a new episode of fever or clinical instability, and only 2 new BSIs were identified after 48 hours of empiric antibiotics and persistent fever. A contaminated BC was identified more frequently in post-antibiotic cultures. Conclusions: In the absence of new fever or clinical instability, BCs beyond 48 hours of persistent fever have limited yield. Opportunity exists to optimize BC collection in this population and reduce the burden of unnecessary tests on patients, healthcare workers, and hospitals.]]> Mon 21 Nov 2022 15:10:53 AEDT ]]> Examining health-related quality of life in pediatric cancer patients with febrile neutropenia: Factors predicting poor recovery in children and their parents https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48462 Fri 17 Mar 2023 12:14:40 AEDT ]]>